Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Joseph P. Doyle"'
Autor:
Parveen Fathima, Mark Jones, Reena D’Souza, James Totterdell, Nada Andric, Penelope Abbott, Richard Norman, Kirsten Howard, Wendy Cheng, Alisa Pedrana, Joseph S. Doyle, Jane Davies, Thomas Snelling
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-14 (2024)
Abstract Background Untreated hepatitis C virus (HCV) infection can result in cirrhosis and hepatocellular cancer. Direct-acting antiviral (DAA) therapies are highly effective and have few side effects compared to older interferon-based therapy. Desp
Externí odkaz:
https://doaj.org/article/da79493bad0a407286619bccafb836ca
Autor:
Andrew B Forbes, Jessica Kasza, Thomas L Snelling, David Anderson, Joseph S Doyle, Peter Higgs, Margaret E Hellard, Nick Scott, Alisa E Pedrana, Alexander J Thompson, Jessica Howell, Timothy Spelman, Beatriz Camesella, Imogen Elsum, Kico Chan, Mark A Stoové, Paul M Dietze, Mellissa Bryant, Katherine Heath, Rodney Guzman, Caitlin Douglass, Amanda Wade, Kate Allardice, Sally Von Bibra, Jacqui Richmond, Nada Andric, Rachel Sacks‐Davis
Publikováno v:
BMJ Open, Vol 14, Iss 7 (2024)
Introduction Despite universal access to government-funded direct-acting antivirals (DAAs) in 2016, the rate of hepatitis C treatment uptake in Australia has declined substantially. Most hepatitis C is related to injecting drug use; reducing the hepa
Externí odkaz:
https://doaj.org/article/e78a8ff3a766436ca40eda23df6e0411
Autor:
Mark J. Hayes, Emma Beavon, Michael W. Traeger, John F. Dillon, Andrew Radley, Suzanne Nielsen, Christopher J. Byrne, Jacqui Richmond, Peter Higgs, Margaret E. Hellard, Joseph S. Doyle
Publikováno v:
EClinicalMedicine, Vol 69, Iss , Pp 102489- (2024)
Summary: Background: The World Health Organization seeks to eliminate viral hepatitis as a public health threat by 2030. This review and meta-analysis aims to evaluate the effectiveness of programs for hepatitis B and C testing and treatment in commu
Externí odkaz:
https://doaj.org/article/8d603d4e61e5468a974dbc8ce450e97f
Autor:
Joshua Dawe, Megan Hughes, Shannon Christensen, Louisa Walsh, Jacqueline A. Richmond, Alisa Pedrana, Anna L. Wilkinson, Louise Owen, Joseph S. Doyle, on behalf of the EC Australia Partnership
Publikováno v:
BMC Public Health, Vol 23, Iss 1, Pp 1-14 (2023)
Abstract Introduction Australia has experienced sustained reductions in hepatitis C testing and treatment and may miss its 2030 elimination targets. Addressing gaps in community-based hepatitis C prescribing in priority settings that did not have, or
Externí odkaz:
https://doaj.org/article/e51deaf20f1c495da967818e7ca204c7
Autor:
Christine Roder, Carl Cosgrave, Kathryn Mackie, Bridgette McNamara, Joseph S. Doyle, Amanda J. Wade
Publikováno v:
Viruses, Vol 16, Iss 6, p 979 (2024)
Increasing testing is key to achieving hepatitis C elimination. This retrospective study aimed to assess the testing cascade of patients at a regional hospital in Victoria, Australia, who inject drugs or are living with hepatitis C, to identify misse
Externí odkaz:
https://doaj.org/article/04589bc2fb634603bd8499bb52fe3a16
Autor:
Anna C. Hearps, Nikil Vootukuru, Salimeh Ebrahimnezhaddarzi, Brendan L. Harney, Irene Boo, Long Nguyen, Damian Pavlyshyn, Paul M. Dietze, Heidi E. Drummer, Alexander J. Thompson, Anthony Jaworowski, Margaret E. Hellard, Rachel Sacks-Davis, Joseph S. Doyle
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundHepatitis C virus (HCV) infections are more prevalent in people who inject drugs (PWID) who often experience additional health risks. HCV induces inflammation and immune alterations that contribute to hepatic and non-hepatic morbidities. It
Externí odkaz:
https://doaj.org/article/6b2719639d214732a42d052dd72c5ec0
Autor:
Alex Collie, Sophie Hill, Margaret Hellard, Alisa Pedrana, Peng Wang, Stephanie Curtis, Margaret Danchin, Jessica Kaufman, Rebecca Ryan, Joseph S Doyle, Robert Power, Danny Vadasz, Lisa Gibbs, Nick Scott, Jane Oliver, Stephanie Fletcher-Lartey, Caroline Homer, Danielle Horyniak, Anna Wilkinson, Angela Davis, Phoebe Kerr, Mark A Stoové, Anna Bowring, Bronwen Merner, Jack Wallace, Long Nguyen, Edwin Jit Leung Kwong, Katherine Heath, Alexander J Thomas, Freya Saich, Stephanie Munari, Aimee Altermatt, Thi Nguyen, Kathryn Young, Deborah Osborne, Martha Vazquez Corona, Tianhui Ke, Yanqin Zhang, Limya Eisa, Adil Al-Qassas, Deng Malith, Karen Block, Freya Shearer, Niamh Meagher, Ali Hassani, Giovanni Radhitio Putra Sadewo, Garry Robins, Colin Gallagher, Petr Matous, Bopha Roden, Maedeh Aboutalebi Karkavandi, James Coutinho, Chiara Broccatelli, Johan Koskinen, Nicholas Geard, Alison Coelho, Dean Lusher, Katherine B Gibney
Publikováno v:
BMJ Open, Vol 14, Iss 1 (2024)
Introduction Longitudinal studies can provide timely and accurate information to evaluate and inform COVID-19 control and mitigation strategies and future pandemic preparedness. The Optimise Study is a multidisciplinary research platform established
Externí odkaz:
https://doaj.org/article/e17f3df5ae88456c8bd3c32d8414d250
Autor:
Joshua Dawe, Carla Gorton, Rhondda Lewis, Jacqueline A. Richmond, Anna L. Wilkinson, Alisa Pedrana, Mark Stoové, Joseph S. Doyle, Darren Russell
Publikováno v:
Viruses, Vol 16, Iss 5, p 800 (2024)
Background: Understanding the effectiveness of novel models of care in community-based settings is critical to achieving hepatitis C elimination. We conducted an evaluation of a hepatitis C model of care with financial incentives that aimed to improv
Externí odkaz:
https://doaj.org/article/0bc841be68e2459b9a5ac852544bf79c
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 11, Iss 1, Pp 1-8 (2022)
Abstract Background Hospital infection prevention and control (IPC) staff have played a key role in adapting and implementing jurisdictional COVID-19 policy during the current pandemic. We aimed to describe the experiences of IPC staff in Australian
Externí odkaz:
https://doaj.org/article/861c806aa931448baa41e375c9111aad
Autor:
Andrew Stewardson, Joseph Doyle, Joseph S Doyle, Peter Higgs, Sue J Lee, Andrew J Stewardson, Sue Lee, Naomi Runnegar, Spiros Miyakis, Joshua Davis, Steven Tong, Ben Rogers, Natasha Holmes, Eugene Athan, Lucy O Attwood, Mellissa Bryant, Olga Vujovic, Lucy Attwood, Kate McCarthy, Kevin O’Callaghan, Marjoree Sehu, Sarah Sparham
Publikováno v:
BMJ Open, Vol 13, Iss 4 (2023)
Introduction People who inject drugs (PWID) are at risk of invasive infections such as bloodstream infections, endocarditis, osteomyelitis and septic arthritis. Such infections require prolonged antibiotic therapy, but there is limited evidence about
Externí odkaz:
https://doaj.org/article/5cfa248b83b54dbebe463688ad3b21f1